TY  - GEN
AU  - Mills,Anthony
AU  - Mildvan,Donna
AU  - Podzamczer,Daniel
AU  - Fätkenheuer,Gerd
AU  - Leal,Manuel
AU  - Than,Soe
AU  - Valluri,Srinivas R
AU  - Craig,Charles
AU  - McFadyen,Lynn
AU  - Vourvahis,Manoli
AU  - Heera,Jayvant
AU  - Valdez,Hernan
AU  - Rinehart,Alex R
AU  - Portsmouth,Simon
TI  - Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients:  randomized, open-label pilot study
SN  - 1944-7884
PY  - 2013///0308
KW  - Adenine
KW  - analogs & derivatives
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Anti-HIV Agents
KW  - therapeutic use
KW  - Atazanavir Sulfate
KW  - CCR5 Receptor Antagonists
KW  - CD4 Lymphocyte Count
KW  - Cyclohexanes
KW  - adverse effects
KW  - Deoxycytidine
KW  - Drug Therapy, Combination
KW  - Emtricitabine
KW  - Female
KW  - HIV Fusion Inhibitors
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - Humans
KW  - Male
KW  - Maraviroc
KW  - Middle Aged
KW  - Oligopeptides
KW  - Organophosphonates
KW  - Pilot Projects
KW  - Pyridines
KW  - RNA, Viral
KW  - blood
KW  - Ritonavir
KW  - Tenofovir
KW  - Triazoles
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/QAI.0b013e31827b51b5
ER  -